Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2000
07/13/2000WO2000011148A3 Cold-shock regulatory elements, constructs thereof, and methods of use
07/13/2000WO2000010582A3 Probiotic, lactic acid-producing bacteria and uses thereof
07/13/2000WO2000009734A9 Methods and compositions for use in spliceosome mediated rna trans-splicing
07/13/2000WO2000009666A9 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
07/13/2000WO2000008196A9 Urate oxidase
07/13/2000WO2000008153A9 Arf-p19, a novel regulator of the mammalian cell cycle
07/13/2000WO2000007545A9 Apoptosis proteins
07/13/2000WO2000006597A9 Endogenous constitutively activated g protein-coupled orphan receptors
07/13/2000WO2000004151A3 Identification and characterization of splice variants of kappa3-related opioid receptor (kor3) gene
07/13/2000WO2000003022A3 Expression of herbicide tolerance genes in plant plastids
07/13/2000WO2000002997A3 Transgenic mouse expressing green fluorescent protein in astrocytes
07/13/2000WO1999066324A9 A bioluminescence resonance energy transfer (bret) system and its use
07/13/2000WO1999063097A9 Caspase-9 deficient animals and the use thereof
07/13/2000WO1999061579A3 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE
07/13/2000WO1999060142A3 Gene therapy vectors and their use in antitumour therapy
07/13/2000WO1997020575A8 Targeted adenovirus vectors
07/13/2000DE19933939A1 Ausnutzung zelleigener Transportsysteme zum Transfer von Nukleinsäuren durch die Kernhülle Utilization of cellular transport systems for the transfer of nucleic acids by the nuclear envelope
07/13/2000DE19900743A1 Neue komplexbildende Proteine New complexing proteins
07/13/2000DE19900635A1 Selektion von monoklonalen Antikörpern Selection of monoclonal antibodies
07/13/2000DE19900511A1 Molekularbiologische Marker für die analytische Elektronenmikroskopie Molecular biological marker for analytical electron microscopy
07/13/2000CA2753331A1 Soluble receptor br43x2 and methods of using
07/13/2000CA2584933A1 Optical sorting method
07/13/2000CA2479551A1 Optical sorting method
07/13/2000CA2364005A1 Production of recombinant monellin using methylotrophic yeast expression system
07/13/2000CA2363839A1 Wound healing and orofacial clefting
07/13/2000CA2363803A1 Polyhydroxyalkanoate biosynthesis associated proteins and coding region in bacillus megaterium
07/13/2000CA2360407A1 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
07/13/2000CA2360396A1 Characterization of a calcium channel family
07/13/2000CA2360022A1 Prokaryotic system designed to monitor protease activity
07/13/2000CA2360011A1 Ordered gene assembly
07/13/2000CA2360000A1 Target molecule attachment to surfaces
07/13/2000CA2359971A1 Modified forms of hepatitis c virus ns3 protease
07/13/2000CA2359892A1 Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41
07/13/2000CA2359853A1 Human chemokine beta-10 mutant polypeptides
07/13/2000CA2358609A1 Process for producing activated protein
07/13/2000CA2358570A1 Protonated/acidified nucleic acids and methods of use
07/13/2000CA2358566A1 Fiber array for contacting chemical species and methods for using and making same
07/13/2000CA2358562A1 Monocyte-derived nucleic acids and related compositions and methods
07/13/2000CA2358548A1 Co-expression of proteins
07/13/2000CA2358543A1 Human desaturase gene and uses thereof
07/13/2000CA2358049A1 Silent inducible virus replicons and uses thereof
07/13/2000CA2358014A1 Gene therapy to promote angiogenesis
07/13/2000CA2357996A1 Streptococcal abc transporter protein
07/13/2000CA2357986A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
07/13/2000CA2357950A1 Therapeutic phosphodiesterase inhibitors
07/13/2000CA2357830A1 Construct of recombinant nucleic acids circularised by dna compacting agents
07/13/2000CA2357811A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity
07/13/2000CA2357807A1 Human seven-transmembrane receptors
07/13/2000CA2357775A1 Method for sequencing dna using a microfluidic device
07/13/2000CA2357677A1 Insulin-synthesis genes
07/13/2000CA2357146A1 Human cyclic nucleotide pdes
07/13/2000CA2357018A1 Ribonucleotide reductase large subunit (r1) cdna and uses thereof
07/13/2000CA2356937A1 Recombinant herpes simplex virus useful for treating neoplastic disease
07/13/2000CA2356861A1 Method of identifying nucleic acids
07/13/2000CA2356597A1 Process for producing transglutaminase
07/13/2000CA2356412A1 Screening method
07/13/2000CA2356401A1 Expression and export of anti-obesity proteins as fc fusion proteins
07/13/2000CA2355967A1 Astrocytes, their preparation and uses thereof
07/13/2000CA2355859A1 Gene therapy-1
07/13/2000CA2354638A1 Expression of secreted human alpha-fetoprotein in transgenic animals
07/12/2000EP1018649A2 Immunochromatographic device and method for multiplex detection of multiple analytes
07/12/2000EP1018560A1 Vectors for treating cancer
07/12/2000EP1018559A1 Phosphodiesterase enzymes
07/12/2000EP1018558A2 Hepatitis C Virus Epitopes
07/12/2000EP1018557A2 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
07/12/2000EP1018556A1 Chimeric and/or growth-restricted flaviviruses
07/12/2000EP1018555A2 Chimeric papilomavirus-like particles
07/12/2000EP1018554A1 Gene related to an incompatible plant-pathogen interaction
07/12/2000EP1018553A1 Transgenic plants with divergent SCaM4 or SCaM5 gene to achieve multiple disease resistance
07/12/2000EP1018552A1 Production of pluripotent granulocyte colony-stimulating factor
07/12/2000EP1018551A1 Megsin protein
07/12/2000EP1018550A2 Allergenic protein and peptides from house dust mite and uses thereof
07/12/2000EP1018549A1 Method for isolating dna
07/12/2000EP1018545A1 Microbial agricultural chemical
07/12/2000EP1018518A2 Use of autoantibodies for tumor therapy and prophylaxis
07/12/2000EP1018344A2 HLA-restricted hepatitis B virus CTL epitopes
07/12/2000EP1018016A1 Immunoassay to detect herpesvirus specific igm
07/12/2000EP1018009A1 Homogeneous method for detecting and/or determining phosphorylating activity in a biological material
07/12/2000EP1018003A1 Modulators of dna cytosine-5 methyltransferase and methods for use thereof
07/12/2000EP1017980A2 Methods of the identification of pharmaceutically active compounds
07/12/2000EP1017856A1 Method and kit for evaluation of hiv mutations
07/12/2000EP1017855A1 Methods of synthesizing polynucleotides by ligation of multiple oligomers
07/12/2000EP1017854A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immnunoreceptors
07/12/2000EP1017853A1 Normalized nucleic acid libraries and methods of production thereof
07/12/2000EP1017851A1 ALLELIC VARIANTS OF THE PHOSPHOLIPASE C-$g(g)1 GENE ASSOCIATED WITH BIPOLAR DISORDER
07/12/2000EP1017850A2 Genetic sequences, diagnostic and/or quantification methods for the identification of staphylococci strains
07/12/2000EP1017849A1 Amplification method for a polynucleotide
07/12/2000EP1017848A2 Nucleic acid sequence analysis
07/12/2000EP1017847A1 Method of mapping restriction sites in polynucleotides
07/12/2000EP1017846A1 Control of immune responses by modulating activity of glycosyltransferases
07/12/2000EP1017843A1 Method for determining active agents
07/12/2000EP1017841A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes
07/12/2000EP1017838A2 Expression of genes in hematopoietic stem cells in hischaemic conditions
07/12/2000EP1017837A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
07/12/2000EP1017836A2 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
07/12/2000EP1017835A1 Methods of using cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy
07/12/2000EP1017834A1 Methods for coexpression of more than one gene using at least one internal ribosome entry site (ires)
07/12/2000EP1017833A1 Petal-specific promoter and method for obtaining plants having flowers with no petals
07/12/2000EP1017832A1 Microspore-specific promoter and method for obtaining hybrid plants
07/12/2000EP1017831A2 Gene silencing materials and methods
1 ... 3214 3215 3216 3217 3218 3219 3220 3221 3222 3223 3224 3225 3226 3227 3228 3229 3230 3231 3232 3233 3234 ... 4023